Clinical Trial Update: Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial examining proton SBRT in combination with immunotherapy for recurrent or progressive head and neck cancer has been termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Head and Neck Cancer | Status: TERMINATED